Financial Performance - In 2024, the company achieved a revenue of 613.67 million yuan, a decrease of 5.06% year-on-year, with conventional business revenue at 533.10 million yuan, an increase of 10.54% [3] - Non-conventional business revenue was 54.19 million yuan, down 63.55% year-on-year; net profit attributable to shareholders was 121.93 million yuan, a decrease of 53.13% [3] - In Q1 2025, the company reported a revenue of 155.30 million yuan, an increase of 8.61% year-on-year; non-conventional business revenue was 4.95 million yuan, down 63.42% [3] - Net profit for Q1 2025 was 22.64 million yuan, a decrease of 48.27% year-on-year, primarily due to fluctuations in financial returns and rising operational costs [3] Business Strategy and Development - The company is actively responding to changes in tariff policies by utilizing local warehousing resources and enhancing inventory measures [4] - Investments in subsidiaries in Suzhou and Taizhou have not yet yielded scale benefits, with ongoing efforts to optimize local teams and automate processes [4] - Focus on overseas development includes establishing a subsidiary in South Korea and enhancing local sales efforts in Japan and South Korea [5] - The company aims to leverage geographical advantages in the U.S. and Canada for localized production and market expansion [5] Investment and M&A Plans - The company is pursuing investments and acquisitions in areas such as reagents, consumables, automation equipment, and synthetic biology [5] - Future acquisitions will prioritize complementary product technology capabilities and focus on upstream and downstream enterprises related to the company's business [5] - The company emphasizes the importance of reasonable valuation in investment decisions to effectively control risks [5] CRO Business Direction - The CRO business is facing profit pressure due to market demand changes and increased competition [7] - The company plans to enhance quality and efficiency through technology upgrades and process optimization to improve project success rates and reduce costs [7] - Resource allocation will be strategically balanced to achieve revenue and profit goals across different service types [7]